Flipped out: Structure-guided design of selective pyrazolylpyrrole ERK inhibitors

被引:107
|
作者
Aronov, Alex M. [1 ]
Baker, Christopher [1 ]
Bemis, Guy W. [1 ]
Cao, Jingrong [1 ]
Chen, Guanjing [1 ]
Ford, Pamella J. [1 ]
Germann, Ursula A. [1 ]
Green, Jeremy [1 ]
Hale, Michael R. [1 ]
Jacobs, Marc [1 ]
Janetka, James W. [1 ]
Maltais, Francois [1 ]
Martinez-Botella, Gabriel [1 ]
Namchuk, Mark N. [1 ]
Straub, Judy [1 ]
Tang, Qing [1 ]
Xie, Xiaoling [1 ]
机构
[1] Vertex Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
D O I
10.1021/jm061381f
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The Ras/Raf/MEK/ERK signal transduction is a key oncogenic pathway implicated in a variety of human cancers. We have identified a novel series of pyrazolylpyrroles as inhibitors of ERK. Aided by the discovery of two distinct binding modes for the pyrazolylpyrrole scaffold, structure-guided optimization culminated in the discovery of 6p, a potent and selective inhibitor of ERK.
引用
收藏
页码:1280 / 1287
页数:8
相关论文
共 50 条
  • [1] Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2
    Ward, Richard A.
    Coldough, Nicola
    Challinor, Mairi
    Debreczeni, Judit E.
    Eckersley, Kay
    Fairley, Gary
    Feron, Lyman
    Flemington, Vildd
    Graham, Mark A.
    Greenwood, Ryan
    Hoperoft, Philip
    Howard, Tina D.
    James, Michael
    Jones, Clifford D.
    Jones, Christopher R.
    Renshaw, Jonathan
    Roberts, Karen
    Snow, Lindsay
    Tonge, Michael
    Yeung, Kay
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (11) : 4790 - 4801
  • [2] Structure-guided design of potent, selective, and orally bioavailable Tankyrase inhibitors
    Bregman, Howard
    DiMauro, Erin
    Chakka, Nagasree
    Guzman-Perez, Angel
    Hua, Zihao
    Huang, Hongbing
    Martin, Matthew
    Buchanan, John
    Gunaydin, Hakan
    Huang, Xin
    Huang, Liyue
    Wilson, Cindy
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [3] Structure-Guided Design of Selective Inhibitors of Neuronal Nitric Oxide Synthase
    Huang, He
    Li, Huiying
    Martasek, Pavel
    Roman, Linda J.
    Poulos, Thomas L.
    Silverman, Richard B.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (07) : 3024 - 3032
  • [4] Structure-Guided Development of Selective RabGGTase Inhibitors
    Bon, Robin S.
    Guo, Zhong
    Stigter, E. Anouk
    Wetzel, Stefan
    Menninger, Sascha
    Wolf, Alexander
    Choidas, Axel
    Alexandrov, Kirill
    Blankenfeldt, Wulf
    Goody, Roger S.
    Waldmann, Herbert
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (21) : 4957 - 4961
  • [5] Structure-Guided Strategy for the Development of Potent Bivalent ERK Inhibitors
    Lechtenberg, Bernhard C.
    Mace, Peter D.
    Sessions, E. Hampton
    Williamson, Robert
    Stalder, Romain
    Wallez, Yann
    Roth, Gregory P.
    Ried, Stefan J.
    Pasquale, Elena B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (07): : 726 - 731
  • [6] Novel Aromatase Inhibitors by Structure-Guided Design
    Ghosh, Debashis
    Lo, Jessica
    Morton, Daniel
    Valette, Damien
    Xi, Jingle
    Griswold, Jennifer
    Hubbell, Susan
    Egbuta, Chinaza
    Jiang, Wenhua
    An, Jing
    Davies, Huw M. L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (19) : 8464 - 8476
  • [7] Structure-Guided Design of Novel, Potent, and Selective Macrocyclic Plasma Kallikrein Inhibitors
    Li, Zhe
    Partridge, James
    Silva-Garcia, Abel
    Rademacher, Peter
    Betz, Andreas
    Xu, Qing
    Sham, Hing
    Hu, Yunjin
    Shan, Yuqing
    Liu, Bin
    Zhang, Ying
    Shi, Haijuan
    Xu, Qiong
    Ma, Xubo
    Zhang, Li
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (02): : 185 - 190
  • [8] Structure-Guided Development of-Selective TbcatB Inhibitors
    Mallari, Jeremy P.
    Shelat, Anang A.
    Kosinski, Aaron
    Caffrey, Conor R.
    Connelly, Michele
    Zhu, Fangyi
    McKerrow, James H.
    Guy, R. Kiplin
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (20) : 6489 - 6493
  • [9] Structure-Guided Design of Potent and Selective Pyrimidylpyrrole Inhibitors of Extracellular Signal-Regulated Kinase (ERK) Using Conformational Control
    Aronov, Alex M.
    Tang, Qing
    Martinez-Botella, Gabriel
    Bemis, Guy W.
    Cao, Jingrong
    Chen, Guanjing
    Ewing, Nigel P.
    Ford, Pamella J.
    Germann, Ursula A.
    Green, Jeremy
    Hale, Michael R.
    Jacobs, Marc
    Janetka, James W.
    Maltais, Francois
    Markland, William
    Namchuk, Mark N.
    Nanthakumar, Suganthini
    Poondru, Srinivasu
    Straub, Judy
    ter Haar, Ernst
    Xie, Xiaoling
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (20) : 6362 - 6368
  • [10] Structure-Guided Design of Group I Selective p21-Activated Kinase Inhibitors
    Crawford, James J.
    Lee, Wendy
    Aliagas, Ignacio
    Mathieu, Simon
    Hoeflich, Klaus P.
    Zhou, Wei
    Wang, Weiru
    Rouge, Lionel
    Murray, Lesley
    La, Hank
    Liu, Ning
    Fan, Peter W.
    Cheong, Jonathan
    Heise, Christopher E.
    Ramaswamy, Sreemathy
    Mintzer, Robert
    Liu, Yanzhou
    Chao, Qi
    Rudolph, Joachim
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (12) : 5121 - 5136